INTRODUCTION
Phagocytosis is an important physiological process by which macrophages, neutrophils, and other cells actively ingest and destroy invading foreign microorganisms as well as apoptotic cells and abnormal particles within the body. Aberrant phagocytosis has been implicated in the pathology of multiple sclerosis, Alzheimer disease, and atherosclerosis (1) (2) (3) . Deficient phagocytosis leads to severe and recurrent bacterial and fungal infections in affected individuals (4) . Moreover, it is increasingly advisable to counterscreen new immunomodulatory drugs for effects on phagocytosis.
The most widely used experimental targets for phagocytosis assays include latex beads, zymosan, and bacteria (5) . Traditionally test particles are labeled with fluorescein or rhodamine dyes for detection by microscopy or by flow cytometry. Two major deficiencies associated with the use of traditional dyes are the difficulty in distinguishing adherent from ingested particles and the quenching of fluorescent labels in the acidic environment of the phagosome (5) . In an attempt to overcome these deficiencies, recent techniques have been developed to distinguish extracellular and intracellular particles by using plasma membrane-impermeant quenching agents, such as ethidium bromide, trypan blue, and dye-specific antibodies, which selectively quench extracellular fluorescence (5, 6 largely incompatible with flow cytometry applications for measurement of phagocytosis; and more importantly, general uptake of ethidium bromide by the cells makes interpretation of the results more difficult (6) . Additionally, pH-sensitive fluorescence dyes have been employed extensively in phagocytosis research, but in most cases their use is associated with spectral shifts and decreases in fluorescence intensity at the acidic pH found within phagosomes (5) (6) (7) (8) . We have improved upon existing methods and developed a novel labeling approach for studying phagocytosis using the pH-sensitive cyanine dye CypHer5E™ (9), which is minimally fluorescent at neutral pH outside the cell, but highly fluorescent in the acidic environment of the phagosome [pKa approximately 7.3; excitation peak 650 nm/emission peak 670 nm (9) ]. Cypher5E can be used to label all standard test particles while overcoming the disadvantages associated with the use of traditional dyes.
MATERIALS AND METHODS

CypHer5E Conjugation to Target Particles
CypHer5E mono N-hydroxysuccinimide (NHS) ester was obtained from GE Healthcare (formerly Amersham Biosci-ences, Piscataway, NJ, USA). One-and three-micron Polybead Amino latex particles were purchased from PolySciences (Warrington, PA, USA), and zymosan was obtained from Sigma (St. Louis, MO, USA). For labeling, 0.5 mL 1-or 3-μm latex particles was spun down at 3000× g for 5 min and resuspended in 0.5 mL 0.1 M sodium carbonate (pH 9.0), which resulted in a final concentration of 1.6 × 10 9 particles/mL or 4.5 × 10 10 particles/mL for 1-and 3-μm particles, respectively. Dried zymosan was resuspended in 0.1 M sodium carbonate (pH 9.0) at a final concentration of 10 mg/mL. CypHer5E mono NHS ester was dissolved in 0.1 M sodium carbonate (pH 9.0) at 100 mg/mL. The labeling reaction for the latex particles was initiated by adding 0.3 mg CypHer5E mono NHS ester to the 0.5 mL particle suspension. For zymosan, 0.05 mg CypHer5E mono NHS ester was added to 10 mg suspended zymosan. The mixtures were then allowed to react for 2 h at room temperature with constant agitation. Labeled particles were removed from the reaction mixture by centrifugation at 3000× g (300× g for zymosan). Particles were resuspended in 20 mL phosphate-buffered saline (PBS; Invitrogen, Carlsbad, CA, USA) and washed again by centrifugation three more times. The final pellet was resuspended in PBS and kept at 4°C. Particle preparation was then tested microscopically to assure that background is no brighter than a control field with no CypHer5E present.
Phagocytosis Assays
THP-1 and WBC264-9C cell lines were from ATCC (Manassas, VA, USA). Human umbilical vein endothelial cells (HUVECs) were from Cambrex (Walkersville, MD, USA). Primary human monocytes and neutrophils were isolated from heparinized whole blood obtained by venipuncture, using Dextran 500 (GE Healthcare) sedimentation and discontinuous Ficoll ® (GE Healthcare) gradients as described (10), and used within 4 h. Monocytes were further purified using MACS ® Human Monocyte Isolation Kit II (Miltenyi Biotec, Auburn, CA, USA). Immature dendritic cells (DCs) were derived from human blood monocytes using granulocyte macrophage colony-stimulating factor (GM-CSF)/interleukin 4 (IL-4) treatment protocol as described previously (10) . Phagocytes were labeled with Cell Tracker™ Green (Invitrogen) as a cellspecific marker and used in a 96-well format.
To assure opsonization of target particles, all phagocytosis assays were conducted in the presence of 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA). Additionally, in some experiments, labeled particles were preopsonized by incubation at 37°C for 1 h with 5 mg/mL human immunoglobulin G (IgG; Sigma) or with fresh FBS followed by a wash and suspension in PBS (see the Results and Discussion section). To induce phagocytosis, particles were added to wells of a 96-well plate containing cells and subjected to a 1-min centrifugation at 300× g to promote interaction between cells and particles. In a typical experiment, 20,000 phagocytes were mixed with 2-to 10-fold excess of CypHer5E-conjugated particles and incubated 1 to18 h in 150 μL RPMI1640 medium containing 10% FBS (Invitrogen). Cytochalasin D, genistein, and piceatannol (all from Sigma) were added as phagocytosis inhibitors when necessary and preincubated with cells for 30 min before the addition of beads.
Microscopy and Image Analysis
Cellular imaging was performed on IN Cell Analyzer 1000 and 3000 (GE Healthcare) using a 10× or 20× objective and fluorescein isothiocyanate (FITC)/Cy™5 excitation/emission filters. Analysis was performed using Granularity Analysis and Object Intensity Analysis Modules within the IN Cell Analysis system software suite.
RESULTS AND DISCUSSION
To set up the CypHer5E-based phagocytosis assay, we conjugated CypHer5E mono NHS ester to 1-and 3-μm latex particles and zymosan. CypHer5E mono NHS ester will label any compounds or particles containing free amino groups and may be used to label all standard particles used in phagocytosis research. In addition to phagocytosis targets, we successfully used CypHer5E labeling to study the uptake of 10-nm nanoparticles and low-density lipoprotein through endocytosis (A. Beletskii and L.Yu, unpublished). To assure efficient uptake of labeled particles, all phagocytosis assays were conducted in the presence of 10% FBS. We found that precoating of particles with human IgG or FBS (see the Materials and Methods section) had little effect on their uptake, and the presence of 10% FBS during the assay was sufficient for efficient phagocytosis of particles. We found that over a 32-fold range of concentrations (0.375-12 particles/ cell), the uptake was very efficient, and after overnight incubation, most of the particles were internalized.
Phagocytosed CypHer5E-conjugated particles exhibited a large increase in fluorescence intensity compared with adherent beads and beads in the medium (Figure 1, A-D) . Time course studies (results not shown) indicated that increased fluorescence associated with particle phagocytosis was observable about 30 min after the start of the phagocytosis reaction. Using IN Cell Analyzer 1000 and 3000 systems for detection, 3-μm latex beads showed a 2-to 6-fold increase in fluorescence after ingestion compared with 3-μm beads in the media (Figure 1, A and B) , while 1-μm latex beads and zymosan particles were not detectable in the media or when adherent to cells (Figure 1, C and D) . Extremely low background from uningested particles is highly advantageous and translates into high assay robustness.
We have demonstrated that CypHer5E-labeled particles can be used to study phagocytosis in a wide variety of cell types including primary human monocytes (not shown) and primary human immature dendritic cells ( Figure 1C) . We extended previous reports that primary HUVECs can internalize zymosan particles (11) by demonstrating the phagocytosis of 3-μm CypHer5E latex beads ( Figure 1B) . The human monocytic THP-1 cell line exhibited robust phagocytosis of CypHer5E beads after an overnight treatment with 10 nM phorbol ester (phorbol myristate acetate; PMA) (data available upon request). While we observed phagocytosis of the CypHer5E beads by primary human neutrophils, the difference in fluorescence intensity between internalized particles and particles in the medium was minimal. This can be attributed to a greatly decreased acidity of phagosomes formed by neutrophils compared with phagosomes formed by other phagocytic cells (8) .
We determined that two commonly available image analysis principles, also included within the IN Cell 3000 software suite, may be used to analyze phagocytosis of CypHer5E-conjugated particles by fluorescent microscopy. Granularity analysis quantitates red phagocytosed beads (granules) within the area marked by cell-specific dye and yields normalized data. Object intensity analysis counts highly fluorescent beads inside the phagosomes, filters out weakly fluorescent beads in the medium, and does not require cell staining. Depending on the need to normalize data or the availability of cell staining, either principle can be used to measure the extent of CypHer5E-conjugated particle phagocytosis. The granularity analysis module for the IN Cell Analyzer 3000 was used to measure inhibition of 3-μm CypHer5E bead phagocytosis by cytochalasin D in WBC264-9C macrophages to determine if CypHer5E-conjugated beads could be used for the screening of compounds affecting phagocytosis (Figure 2A) . A cytochalasin D concentration of 1.4 μM is required to inhibit the phagocytosis level to 50% of the uninhibited response (the 50% inhibition concentration; IC 50 ), which agrees well with the published values (12) . Similar experiments were performed with the tyrosine kinase inhibitor genistein and the Syk-family kinase inhibitor piceatannol, and inhibition of phagocytosis was observed with an IC 50 of approximately 120 μM for both compounds in the WBC264-9E cell line.
To demonstrate that CypHer5E-labeled particles can be used for high-throughput screening, we determined the Zfactor (13) by treating 96 wells of a 384-well plate containing WBC264-9C macrophages with 10 μM cytochalasin D while leaving another 96 wells untreated ( Figure 2B ). The Z-factor is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements and, therefore, is suitable for assay quality assessment (13) . As can be seen from Figure 2B , a Z-factor of 0.45 for the assay described here approaches the value of 0.5, commonly considered acceptable for high-throughput cellular screening, and is well above the minimum of 0.2-0.3 required for meaningful cell-based assays.
In conclusion, we have presented a simple and convenient assay for studying phagocytosis. The fluorescent signal generated by internalized CypHer5E-labeled particles is easily distinguishable from the background of noninternalized particles, which results in increased assay robustness. Additionally, CypHer5E-labeled particles are resistant to fluorescence quenching observed in the aggressive and acidic environment of the phagosome with the traditional dyes (5). However, application of the assay in neutrophils is limited due to decreased acidity of phagosomes formed by neutrophils compromising internalized particle fluorescence intensity. The assay is superior to existing protocols, because it allows the easy differentiation of true phagocytosis from particle adherence in microscopy-based measurements of phagocytosis and potentially can also be used in flow cytometry-based assays. 
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